ELVN | | Enliven Therapeutics, Inc. | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Apr 11, 2024 | Option Exercise | $13.08 | 60,000 | 784,932 | 30,000 | Apr 15, 2024, 07:06 PM |
ELVN | | Enliven Therapeutics, Inc. | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Apr 01, 2024 | Sale | $9.86 | 24,000 | 236,586 | 12,000 | Apr 03, 2024, 09:30 PM |
ELVN | | Enliven Therapeutics, Inc. | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Feb 29, 2024 | Sale | $8.77 | 24,000 | 210,446 | 12,000 | Mar 04, 2024, 05:55 PM |
ELVN | | Enliven Therapeutics, Inc. | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Jan 29, 2024 | Option Exercise | $8.49 | 24,000 | 203,696 | 12,000 | Jan 31, 2024, 09:22 PM |
ELVN | | Enliven Therapeutics, Inc. | Lyssikatos Joseph P | Chief Scientific Officer | Dec 29, 2023 | Sale | $7.70 | 24,000 | 184,821 | 12,000 | Jan 03, 2024, 07:01 PM |
ELVN | | Enliven Therapeutics, Inc. | Lyssikatos Joseph P | Chief Scientific Officer | Dec 22, 2023 | Sale | $7.09 | 13,092 | 92,862 | 6,546 | Dec 26, 2023, 07:32 PM |
ELVN | | Enliven Therapeutics, Inc. | Lyssikatos Joseph P | Chief Scientific Officer | Dec 21, 2023 | Sale | $7.06 | 40 | 282 | 20 | Dec 26, 2023, 07:32 PM |
ELVN | | Enliven Therapeutics, Inc. | Lyssikatos Joseph P | Chief Scientific Officer | Dec 19, 2023 | Sale | $7.06 | 400 | 2,824 | 200 | Dec 21, 2023, 04:29 PM |
ELVN | | Enliven Therapeutics, Inc. | Lyssikatos Joseph P | Chief Scientific Officer | Dec 20, 2023 | Sale | $7.07 | 17,376 | 122,776 | 8,688 | Dec 21, 2023, 04:29 PM |
ELVN | | Enliven Therapeutics, Inc. | Lyssikatos Joseph P | Chief Scientific Officer | Nov 03, 2023 | Sale | $7.10 | 17,092 | 121,322 | 8,546 | Nov 06, 2023, 04:43 PM |
ELVN | | Enliven Therapeutics, Inc. | Lyssikatos Joseph P | Chief Scientific Officer | Sep 29, 2023 | Sale | $7.37 | 24,000 | 176,938 | 12,000 | Oct 03, 2023, 07:40 PM |